Showing results (1501-1510 of 2,726) with videos related to
Sort By:
Pageof 273
Bioanalysis|September 7, 2019
Perspectives on the draft ICH-M10 guidance: an interview with Eric J WoolfEric J WoolfBioanalysis|September 12, 2019
A multidrug LC-MS/MS method for the determination of five immunosuppressants in oral fluidLucía Paniagua-González, Elena Lendoiro, Esteban Otero-Antón, et al.Bioanalysis|September 26, 2022
Development and validation of an LC-MS/MS method for the quantification of fascin proteins in human serumKe Li, Zhiling Zhang, Kai Wang, et al.Bioanalysis|September 27, 2022
Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samplesOliver Langer, Jinho Song, Min Sun Choi, et al.Bioanalysis|October 8, 2022
Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppressionAbbie D Leino, John Takyi-Williams, Bo Wen, et al.Bioanalysis|March 8, 2021
Innovation in bioanalytical strategies and <i>in vitro</i> drug-drug interaction study approaches in drug discoverySaraswathisreeram Pranush Kumar, Deeki Doma Sherpa, Amit Kumar Sahu, et al.Bioanalysis|August 6, 2016
A simple, effective approach for rapid development of high-throughput and reliable LC-MS/MS bioanalytical assaysLong Yuan, Anne-Françoise Aubry, Qin C JiBioanalysis|September 4, 2025
Overcoming bioanalytical challenges during the development of risdiplam for the treatment of spinal muscular atrophyKatja Heinig, Pawel Dzygiel, Luca FerrariBioanalysis|June 26, 2015
Current industrial practices and regulatory requirements to assess analyte and reagent stability using ligand-binding assaysJin Wang, William Nowatzke, Mark MaBioanalysis|June 26, 2015
Integration of microfluidic LC with HRMS for the analysis of analytes in biofluids: past, present and futurePaul D Rainville, James I Langridge, Mark D Wrona, et al.Pageof 273